Tandem Diabetes Care (TNDM) Total Liabilities (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Total Liabilities came in at $1.0 billion in Q1 2026, up 33.14% YoY from $766.9 million in Q1 2025, and up 40.64% on a QoQ basis from $725.9 million in Q4 2025.
Tandem Diabetes Care (TNDM) Total Liabilities (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Total Liabilities data on file, last reported at $1.0 billion in Q1 2026.
- Quarterly Total Liabilities rose 33.14% year-over-year to $1.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 33.14% YoY) and the FY2025 annual result came in at $725.9 million, up 3.03% from the prior year.
- Total Liabilities rose to $1.0 billion in Q1 2026, from $725.9 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $1.0 billion in Q1 2026 to a low of $577.9 million in Q1 2022.
- A 5-year average of $689.7 million and a median of $698.0 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities soared 35.84% — and 2023, when it grew 0.03%.
- Tracing TNDM's Total Liabilities over 5 years: stood at $612.8 million in 2022, then gained by 4.27% to $639.0 million in 2023, then advanced by 10.26% to $704.6 million in 2024, then grew by 3.03% to $725.9 million in 2025, then surged by 40.64% to $1.0 billion in 2026.
- The last three Total Liabilities figures came in at $1.0 billion (Q1 2026), $725.9 million (Q4 2025), and $741.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.94 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 3.14 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.83 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.03 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 17.70 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.51 Bn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | 1.02 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Bn |
| Mar 31, 2026 | 1.02 Bn |
| Dec 31, 2025 | 725.94 Mn |
| Sep 30, 2025 | 741.69 Mn |
| Jun 30, 2025 | 742.45 Mn |
| Mar 31, 2025 | 766.85 Mn |
| Dec 31, 2024 | 704.56 Mn |
| Sep 30, 2024 | 720.02 Mn |
| Jun 30, 2024 | 703.63 Mn |
| Mar 31, 2024 | 697.98 Mn |
| Dec 31, 2023 | 639.03 Mn |
| Sep 30, 2023 | 625.91 Mn |
| Jun 30, 2023 | 617.44 Mn |
| Mar 31, 2023 | 615.39 Mn |
| Dec 31, 2022 | 612.84 Mn |
| Sep 30, 2022 | 625.70 Mn |
| Jun 30, 2022 | 586.99 Mn |
| Mar 31, 2022 | 577.90 Mn |
| Dec 31, 2021 | 472.03 Mn |
| Sep 30, 2021 | 460.63 Mn |